Osteoarticular changes in acromegaly

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Killinger, Zdenko ^a   Kužma, Martin ^a   Sterančáková, Lenka ^a   Payer, Juraj ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; OCTREOTIDE; PEGVISOMANT; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; DRUG MECHANISM; FRACTURE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS TUMOR; IMMOBILIZATION; MORBIDITY; OSTEOARTHROPATHY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SECONDARY OSTEOPOROSIS;

EID: 84867355962     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/839282     Document Type: Review

References (31)

1. Giuseppina P., Graziella B., Laura I., Guido S., Valentina M., Mario V., Patrizia T., Prevalence of osteoporosis and vertebral fractures in acromegalic patients. Clinical Cases in Mineral and Bone Metabolism 2011 8 3 37 43
2. Tagliafico A., Resmini E., Ferone D., Martinoli C., Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations. Radiologia Medica 2011 116 5 781 792 2-s2.0-79961210260 10.1007/s11547-011-0671-z
3. Wassenaar M. J. E., Biermasz N. R., Hamdy N. A. T., Zillikens M. C., Van Meurs J. B. J., Rivadeneira F., Hofman A., Uitterlinden A. G., Stokkel M. P. M., Roelfsema F., Kloppenburg M., Kroon H. M., Romijn J. A., Pereira A. M., High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. European Journal of Endocrinology 2011 164 4 475 483 2-s2.0-79953202535 10.1530/EJE-10-1005
4. Colao A., Ferone D., Marzullo P., Lombardi G., Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004 25 1 102 152 2-s2.0-1442326975 10.1210/er.2002-0022 (Pubitemid 38269977)
5. Oh Y., Muller H. L., Pham H., Rosenfeld R. G., Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. The Journal of Biological Chemistry 1993 268 35 26045 26048 2-s2.0-0027373968 (Pubitemid 23361660)
6. Biermasz N. R., Pereira A. M., Smit J. W. A., Romijn J. A., Roelfsema F., Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. Journal of Clinical Endocrinology and Metabolism 2005 90 5 2731 2739 2-s2.0-18844370346 10.1210/jc.2004-2297 (Pubitemid 40686317)
7. Ueland T., Fougner S. L., Godang K., Schreiner T., Bollerslev J., Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. European Journal of Endocrinology 2006 155 5 709 715 2-s2.0-33845271474 10.1530/eje.1.02285 (Pubitemid 44857495)
8. Madiera M., Effects of GH-IGF-1 excess and gonadal status on bone mineral density and body composition in patients with acromegaly. Osteoporosis International 2010 21 12 2019 2025
9. Lieberman S. A., Bjorkengren A. G., Hoffman A. R., Rheumatologic and skeletal changes in acromegaly. Endocrinology and Metabolism Clinics of North America 1992 21 3 615 631 2-s2.0-0026783554
10. AACE Acromegaly Guidelines, American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocrine Practice 2011 17 supplement 4 636 6646
11. Ueland T., GH/IGF-I and bone resorption in vivo and in vitro. European Journal of Endocrinology 2005 152 3 327 332 2-s2.0-15944394729 10.1530/eje.1.01874 (Pubitemid 40439482)
12. Mrak E., Villa I., Lanzi R., Losa M., Guidobono F., Rubinacci A., Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells. Journal of Endocrinology 2007 192 3 639 645 2-s2.0-33947394915 10.1677/joe.1.07073 (Pubitemid 46455966)
13. De Paula F. J. A., Góis-Júnior M. B., Aguiar-Oliveira M. H., Pereira F. D. A., Oliveira C. R. P., Pereira R. M. C., Farias C. T., Vicente T. A. R., Salvatori R., Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene. Clinical Endocrinology 2009 70 1 35 40 2-s2.0-58149144429 10.1111/j.1365-2265.2008.03302.x
14. White H. D., Ahmad A. M., Syed A. A., Clewes A., Peter R., Vora J. P., Fraser W. D., Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients. Clinical Endocrinology 2004 60 4 516 526 2-s2.0-1842633623 10.1111/j.1365-2265.2004. 02010.x (Pubitemid 38482516)
15. Kužma M., Homerová Z., Dlesk A., Koller T., Killinger Z., Vauga P., Lazúrová I., Tomková S., Payer J., Effect of growth hormone on bone status in growth hormone deficient adults. Bratislavské lekárske listy. In press
16. Parkinson C., Kassem M., Heickendorff L., Flyvbjerg A., Trainer P. J., Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. Journal of Clinical Endocrinology and Metabolism 2003 88 12 5650 5655 2-s2.0-0347362889 10.1210/jc.2003-030772 (Pubitemid 38033029)
17. Piovesan A., Terzolo M., Reimondo G., Pia A., Codegone A., Osella G., Boccuzzi A., Paccotti P., Angeli A., Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Hormone and Metabolic Research 1994 26 5 234 237 2-s2.0-0028227535 (Pubitemid 24162468)
18. Kaji H., Sugimoto T., Nakaoka D., Okimura Y., Kaji H., Abe H., Chihara K., Bone metabolism and body composition in Japanese patients with active acromegaly. Clinical Endocrinology 2001 55 2 175 181 2-s2.0-0034828791 10.1046/j.1365-2265.2001.01280.x (Pubitemid 32868581)
19. Ohlsson C., Bengtsson B. Å., Isaksson O. G. P., Andreassen T. T., Slootweg M. C., Growth hormone and bone. Endocrine Reviews 1998 19 1 55 79 2-s2.0-0032468983 (Pubitemid 29122074)
20. Bolanowski M., Daroszewski J., Mdraś M., Zadrozna-Śliwka B., Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. Journal of Bone and Mineral Metabolism 2006 24 1 72 78 2-s2.0-29244434032 10.1007/s00774-005-0649-9 (Pubitemid 41821507)
21. Zgliczynski W., Kochman M., Misiorowski W., Zdunowski P., In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender. Neuroendocrinology Letters 2007 28 5 621 628 2-s2.0-38049133951
22. Ueland T., Ebbesen E. N., Thomsen J. S., Mosekilde L., Brixen K., Flyvbjerg A., Bollerslev J., Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. European Journal of Clinical Investigation 2002 32 2 122 128 2-s2.0-0037003047 10.1046/j.1365-2362. 2002.00944.x (Pubitemid 36232733)
23. Scillitani A., Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clinical Endocrinology 2003 58 6 725 731 (Pubitemid 36702732)
24. Giustina A., Mazziotti G., Canalis E., Growth hormone, insulin-like growth factors, and the skeleton. Endocrine Reviews 2008 29 5 535 559 2-s2.0-49549111375 10.1210/er.2007-0036
25. Bonadonna S., Mazziotti G., Nuzzo M., Bianchi A., Fusco A., De Marinis L., Giustina A., Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. Journal of Bone and Mineral Research 2005 20 10 1837 1844 2-s2.0-25444517599 10.1359/JBMR.050603 (Pubitemid 41361885)
26. Biermasz N. R., Hamdy N. A. T., Pereira A. M., Romijn J. A., Roelfsema F., Long-term maintenance of the anabolic effects of GH on the skeleton in successful treated patients with acromegaly. European Journal of Endocrinology 2005 152 1 53 60 2-s2.0-13244275291 10.1530/eje.1.01820 (Pubitemid 40185453)
27. Killinger Z., Payer J., Lazúrová I., Imrich R., Homérová Z., Kužma M., Rovensk J., Arthropathy in Acromegaly. Rheumatic Disease Clinics of North America 2010 36 4 713 720 2-s2.0-78449269935 10.1016/j.rdc.2010.09.004
28. Chipman J. J., Attanasio A. F., Birkett M. A., Bates P. C., Webb S., Lamberts S. W. J., The safety profile of GH replacement therapy in adults. Clinical Endocrinology 1997 46 4 473 481 2-s2.0-0031007701 (Pubitemid 27242684)
29. Harris A. G., Acromegaly and Its Management 1996 Philadelphia, Pa, USA Lippincott-Raven
30. Wassenaar M. J. E., Biermasz N. R., van Duinen N., van der Klaauw A. A., Pereira A. M., Roelfsena F., Smit J. W. A., Kroon H. M., Kloppenburg M., Romijn J. A., High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. European Journal of Endocrinology 2009 160 3 357 365 2-s2.0-62649096321 10.1530/EJE-08-0845
31. Biermasz N. R., Van Thiel S. W., Pereira A. M., Hoftijzer H. C., Van Hemert A. M., Smit J. W. A., Romijn J. A., Roelfsema F., Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. Journal of Clinical Endocrinology and Metabolism 2004 89 11 5369 5376 2-s2.0-8744276605 10.1210/jc.2004-0669 (Pubitemid 39518410)